We use methods in molecular biology, immunology, and structural biology to study how pathogens interact with the cells of their hosts. We focus on emerging viruses that cause lethal human diseases with limited treatment or vaccine options. These include coronaviruses, filoviruses, arenaviruses, and alphaviruses. We are a part of the Massachusetts Consortium for Pathogen Readiness (MassCPR).
Read an article on our recent Cellpaper: “Escape Artist: Study shows how mutations in SARS-CoV-2 allow the virus to evade immune system defenses“